Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

B

brendaarmit1

@brendaarmit1
Agency
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
About
Posts
8
Topics
4
Shares
0
Groups
1
Followers
2
Following
0

Posts

Recent Best Controversial

  • Inclusion of trial patient characteristics within a Rep CVA
    B brendaarmit1

    @jennifer-carroll Thank you!

    PAAB Q&A

  • Inclusion of trial patient characteristics within a Rep CVA
    B brendaarmit1

    @jennifer-carroll Thanks for your direction on this. Just to confirm, if there is an instance where the patient characteristics are not required in order to interpret the copy, we don't need to include it on the slide. We can; however, create an appendix slide with patient characteristics just in case a Rep is asked by the HCP and it is available for them to use. Of course, this appendix slide will be reviewed by PAAB, but not required as part of the consecutive CVA presentation.

    PAAB Q&A

  • Inclusion of trial patient characteristics within a Rep CVA
    B brendaarmit1

    Are there rules around having to include a slide on the patient population characteristics from the trials within a Rep CVA? Is it acceptable to have this slide in an Appendix, so available if necessary?

    PAAB Q&A

  • Pre-NOC submissions
    B brendaarmit1

    @jennifer-carroll Thank you Jennifer. That does help.

    Non-product branded APS, pre-NOC teasers

  • Pre-NOC submissions
    B brendaarmit1

    @jennifer-carroll Thank you. So, I just want to be really clear on this. We can submit 2 pre-NOC pieces following the submission guidance and we can submit the RMT pre-NOC for the standard opinion review.

    Non-product branded APS, pre-NOC teasers

  • Pre-NOC submissions
    B brendaarmit1

    We are planning on submitting 2 pieces for pre-NOC review and was wondering if the Health Canada directed requirement for a risk minimization tool (RMT) would count as one of the pre-NOC pieces for review since it isn't a 'usual' PAAB review piece.

    Non-product branded APS, pre-NOC teasers

  • Banner ads in different sizes
    B brendaarmit1

    Re: [Banner ads]
    Can you please clarify the need to make a series submission of a banner ad with identical content; however in different sized layouts? I understand that a rectangular ad would have different breakpoints than a square ad; however, a rectangular ad large, medium, small would not.

    PAAB Code

  • Email communication linking to unbranded event
    B brendaarmit1

    Hello,
    My question is, can a pharma company send an email with a link to a CME event or to an association's guidelines page or to a journal article. The email would not come from the brand and would not have mention of the brand.

    PAAB Q&A
  • Login

  • Don't have an account? Register

  • Login or register to search.
  • First post
    Last post
0
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups